BioNTech says collaboration with Pfizer remains unchanged
Tweet
Share
E-mail
The logo of BioNTech is pictured at Biontech's research laboratory for individualised vaccines against cancer in Mainz, Germany, July 27, 2023. REUTERS/Wolfgang Rattay
FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer has not changed, when asked to comment on a report that Pfizer is looking to sell its stake in the German biotech firm.
"We continue to have a close and strong collaboration," a spokesperson said in a statement, adding that BioNTech would not be commenting on any capital market activities by Pfizer.
(Reporting by Ludwig Burger, editing by Thomas Escritt)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia Vera Rubin shown to provide 10x more throughput per megawatt than Blackwell
- Chinese Open LLMs are no threat to memory demand, BofA says
- Moonshot AI eyes $50 billion valuation, Hong Kong IPO after Kimi K3 breakthrough
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
